These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 28890078)

  • 21. Association between hydroxychloroquine intake and damage to the outer nuclear layer in eyes without manifest retinal toxicity.
    Salameh N; Doumit CA; Jalkh E; Nehme J
    BMC Ophthalmol; 2024 Sep; 24(1):414. PubMed ID: 39334015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of morphological features and vascular layers of choroid in diabetic retinopathy using spectral-domain optical coherence tomography.
    Adhi M; Brewer E; Waheed NK; Duker JS
    JAMA Ophthalmol; 2013 Oct; 131(10):1267-74. PubMed ID: 23907153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the outer retinal thickness pixel maps for the screening of hydroxychloroquine retinopathy.
    Tarassoly K; Miraftabi A; Sedaghat A; Parvaresh MM
    Int Ophthalmol; 2023 May; 43(5):1737-1743. PubMed ID: 36414851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early effect of hydroxychloroquine therapy: relationship between cumulative dose and retinal thickness.
    Agarwal P; Wong YH; Dasgupta E; Agarwal R; Livingstone BI; Ramamurthy S; Chyn GS
    Cutan Ocul Toxicol; 2015; 34(3):179-84. PubMed ID: 25068998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CHOROIDAL THICKNESS IN MULTISYSTEMIC AUTOIMMUNE DISEASES WITHOUT OPHTHALMOLOGIC MANIFESTATIONS.
    Ferreira CS; Beato J; Falcão MS; Brandão E; Falcão-Reis F; Carneiro ÂM
    Retina; 2017 Mar; 37(3):529-535. PubMed ID: 27429379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxychloroquine treatment alters retinal layers and choroid without apparent toxicity in optical coherence tomography.
    Polat OA; Okçu M; Yılmaz M
    Photodiagnosis Photodyn Ther; 2022 Jun; 38():102806. PubMed ID: 35288317
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CHOROIDAL VASCULARITY INDEX IN HYDROXYCHLOROQUINE TOXIC RETINOPATHY: A Quantitative Comparative Analysis Using Enhanced Depth Imaging In Spectral Domain Optical Coherence Tomography.
    Halouani S; Le HM; Querques G; Borrelli E; Sacconi R; Battista M; Jung C; Souied EH; Miere A
    Retina; 2023 Jan; 43(1):94-101. PubMed ID: 36201756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for hydroxychloroquine retinopathy in systemic lupus erythematosus: a case-control study with hydroxychloroquine blood-level analysis.
    Lenfant T; Salah S; Leroux G; Bousquet E; Le Guern V; Chasset F; Francès C; Morel N; Chezel J; Papo T; Cacoub P; Mouthon L; Guettrot-Imbert G; Cohen P; Régent A; Mauget-Faÿsse M; Piette JC; Jallouli M; Costedoat-Chalumeau N;
    Rheumatology (Oxford); 2020 Dec; 59(12):3807-3816. PubMed ID: 32442312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.
    de Sisternes L; Hu J; Rubin DL; Marmor MF
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3415-26. PubMed ID: 26024126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of parafoveal cone density in patients taking hydroxychloroquine in the absence of clinically documented retinal toxicity.
    Debellemanière G; Flores M; Tumahai P; Meillat M; Bidaut Garnier M; Delbosc B; Saleh M
    Acta Ophthalmol; 2015 Nov; 93(7):e534-40. PubMed ID: 25989823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.
    Mavrikakis I; Sfikakis PP; Mavrikakis E; Rougas K; Nikolaou A; Kostopoulos C; Mavrikakis M
    Ophthalmology; 2003 Jul; 110(7):1321-6. PubMed ID: 12867385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-Term Progression of Pericentral Hydroxychloroquine Retinopathy.
    Ahn SJ; Seo EJ; Kim KE; Kim YJ; Lee BR; Kim JG; Yoon YH; Lee JY
    Ophthalmology; 2021 Jun; 128(6):889-898. PubMed ID: 33129843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of OCT Retinal Thickness Deviation Map for Hydroxychloroquine Retinopathy Screening.
    Kim KE; Ahn SJ; Woo SJ; Park KH; Lee BR; Lee YK; Sung YK
    Ophthalmology; 2021 Jan; 128(1):110-119. PubMed ID: 32553941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of spectral-domain optical coherence tomography in preterm children: retinal layer thickness and choroidal thickness profiles.
    Park KA; Oh SY
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7201-7. PubMed ID: 23033393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macula pigment optical densitometry changes in hydroxychloroquine use.
    Kabataş N; Özateş S; Avarisli NA; Kakil SB; Özişler C
    Cutan Ocul Toxicol; 2021 Jun; 40(2):115-118. PubMed ID: 33757380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VOLUMETRIC SINGLE-LAYER INNER RETINAL ANALYSIS IN PATIENTS WITH HYDROXYCHLOROQUINE TOXICITY.
    Modi YS; Au A; Parikh VS; Ehlers JP; Schachat AP; Singh RP
    Retina; 2016 Oct; 36(10):1941-50. PubMed ID: 27258672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of oral acetazolamide on cystoid macular edema in hydroxychloroquine retinopathy: a case report.
    Hong EH; Ahn SJ; Lim HW; Lee BR
    BMC Ophthalmol; 2017 Jul; 17(1):124. PubMed ID: 28701214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinal microvascular density analysis in patients with rheumatoid arthritis treated with hydroxychloroquine.
    Esser EL; Zimmermann JA; Storp JJ; Eter N; Mihailovic N
    Graefes Arch Clin Exp Ophthalmol; 2023 May; 261(5):1433-1442. PubMed ID: 36580078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus.
    Martín-Iglesias D; Artaraz J; Fonollosa A; Ugarte A; Arteagabeitia A; Ruiz-Irastorza G
    Lupus; 2019 Apr; 28(4):555-559. PubMed ID: 30755141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence Lifetimes in Patients With Hydroxychloroquine Retinopathy.
    Solberg Y; Dysli C; Möller B; Wolf S; Zinkernagel MS
    Invest Ophthalmol Vis Sci; 2019 May; 60(6):2165-2172. PubMed ID: 31108547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.